NCT05923567View on ClinicalTrials.gov

New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Paancreatic Cancer
Trial Locations (1)

Unknown

Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER